Anel Tankovic

Radiology

3620 Howell Ferry Rd
Duluth, GA 30096

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.

De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.

Journal: Cellular and molecular life sciences : CMLS

Published: May 23, 2023

GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function.

GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function.

Journal: Journal of human genetics

Published: November 03, 2016

Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy.

Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy.

Journal: Molecular pharmacology

Published: October 09, 2016

A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.

A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.

Journal: PloS one

Published: October 08, 2016

Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.

Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.

Journal: American journal of human genetics

Published: August 20, 2016

Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.

Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.

Journal: PLoS genetics

Published: August 11, 2016

GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.

GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.

Journal: American journal of human genetics

Published: April 30, 2016

GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.

GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.

Journal: Annals of clinical and translational neurology

Published: May 20, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026